What the company does
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid …
What the weekly tape is saying
BIIB closed the latest completed week at 3,336 MXN. The 4-week return is 1.1% and the 12-week return is 2.0%. Trend Signal is active, Market Dynamics is -0.13. Setup signature: Balanced read with a 48/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3,235 MXN
- Vs Trend Line
- 3.1%
- Fair Value
- 3,484 MXN
- Vs Fair Value
- -4.3%
- 52W High
- 3,400 MXN
- 52W Low
- 2,395 MXN
- Drawdown
- -1.9%
- Range Position
- 93.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 33 weeks
- 52W Active Weeks
- 33
- 52W Active Breadth
- 63.5%
- Sector Scope
- MX Healthcare
- Sector Rank
- 28 of 78
- Sector Percentile
- 64.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
MX Healthcare
- Tracked Peers
- 78
- 4W Rank
- 42 of 78
- Avg 1W
- -0.7%
- Avg 4W
- 0.4%
- Trend Breadth
- 19.2%
- Positive MD
- 29.5%
MX Drug Manufacturers - General
- Tracked Peers
- 14
- 4W Rank
- 8 of 14
- Avg 1W
- -0.1%
- Avg 4W
- 1.6%
- Trend Breadth
- 21.4%
- Positive RS
- 42.9%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.13
- 4W MD Change
- -554.6%
- Relative Strength
- 5.95
- 4W RS Change
- 2.2%
- Expectation
- Negative
- Probability
- 22.69%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 0
- 13W Average
- 180
- 52W Average
- 186
- Vs 13W
- -
- Vs 52W
- -
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.0%
- 52W Volatility
- 4.3%
- Upside Weeks
- 16
- Downside Weeks
- 17
- Downside Breadth
- 32.7%
- Avg Gain / Loss
- 5.1% / -3.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- MEX
- Country
- MX
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- MXN
- Market Cap
- 494.6B
Opportunity signals
- Trend Signal is active with a 33-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3,336 MXN | 0.0% | 3,235 MXN | 3,484 MXN | -0.13 | 5.95 | 0 | On |
| 5 Jun 2026 | 3,336 MXN | -0.4% | 3,226 MXN | 3,496 MXN | -0.04 | 9.07 | 10 | On |
| 29 May 2026 | 3,350 MXN | 0.0% | 3,208 MXN | 3,509 MXN | 0.05 | 5.92 | 16 | On |
| 22 May 2026 | 3,350 MXN | 1.6% | 3,191 MXN | 3,522 MXN | 0.20 | 6.61 | 1.4K | On |
| 15 May 2026 | 3,298 MXN | -3.0% | 3,169 MXN | 3,534 MXN | 0.03 | 5.82 | 225 | On |
| 8 May 2026 | 3,400 MXN | 0.0% | 3,150 MXN | 3,549 MXN | -0.32 | 6.44 | 0 | On |
| 1 May 2026 | 3,400 MXN | 3.5% | 3,127 MXN | 3,562 MXN | -0.24 | 9.49 | 613 | On |
| 24 Apr 2026 | 3,285 MXN | 10.6% | 3,112 MXN | 3,576 MXN | -0.18 | 3.65 | 0 | On |
| 17 Apr 2026 | 2,970 MXN | -8.6% | 3,087 MXN | 3,587 MXN | 0.07 | -7.20 | 14 | On |
| 10 Apr 2026 | 3,249 MXN | 0.0% | 3,076 MXN | 3,602 MXN | 0.43 | 0.75 | 0 | On |
| 3 Apr 2026 | 3,249 MXN | 0.0% | 3,058 MXN | 3,613 MXN | 0.27 | 0.84 | 0 | On |
| 27 Mar 2026 | 3,249 MXN | -0.6% | 3,039 MXN | 3,625 MXN | 0.04 | 5.01 | 7 | On |
| 20 Mar 2026 | 3,270 MXN | 0.1% | 3,016 MXN | 3,636 MXN | -0.23 | 9.67 | 71 | On |
| 13 Mar 2026 | 3,267 MXN | 0.0% | 2,995 MXN | 3,647 MXN | -0.26 | 6.90 | 0 | On |